STAT3 and diffuse large B-cell lymphoma: We now have strong evidence that STAT3/NF-κB activity driven by either a complex microenvironment in lymphomas or intrinsic genetic lesions is important in the metabolic reprogramming of cells different from OxPhos DLBCL.